PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial

ClinicalTrials.gov ID: NCT02374060

Public ClinicalTrials.gov record NCT02374060. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 22, 2026, 10:55 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID: NCT02374060
Recruitment status: Completed
Study type: Interventional
Phase: Phase 3
Lead sponsor: JHSPH Center for Clinical Trials; Other
Enrollment: 192 participants

Conditions and interventions

Conditions

Interventions

Periocular triamcinolone 40 mg Drug
Intravitreal triamcinolone 4 mg Drug
Dexamethasone intravitreal implant Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 15, 2015
Primary completion: Aug 29, 2017
Completion: Jan 3, 2018
Last update posted: Dec 3, 2018

2015 – 2018

United States locations

U.S. sites: 23
U.S. states: 16
U.S. cities: 20

Facility	City	State	ZIP	Site status
Jules Stein Eye Institute, UCLA	Los Angeles	California	90095	—
University of California, San Francisco	San Francisco	California	94143	—
Anne Bates Leach Eye Hospital, University of Miami Miller School of Medicine	Miami	Florida	33136	—
University of South Florida	Tampa	Florida	33612	—
Emory University	Atlanta	Georgia	30322	—
Northwestern University	Chicago	Illinois	60611	—
Rush University Medical Center	Chicago	Illinois	60612	—
University of Iowa	Iowa City	Iowa	52242	—
Johns Hopkins University	Baltimore	Maryland	21287	—
National Eye Institute, NIH	Bethesda	Maryland	20892	—
Massachusetts Eye and Ear Infirmary	Boston	Massachusetts	02114	—
Ophthalmic Consultants of Boston	Boston	Massachusetts	02114	—
Kellogg Eye Center, University of Michigan	Ann Arbor	Michigan	48105	—
MAYO Clinic	Rochester	Minnesota	55905	—
Washington University School of Medicine	St Louis	Missouri	63110	—
New York Eye and Ear Infirmary	New York	New York	10016	—
Duke Eye Center, Duke University	Durham	North Carolina	27710	—
Scheie Eye Institute, University of Pennsylvania	Philadelphia	Pennsylvania	19104	—
Wills Eye Hospital	Philadelphia	Pennsylvania	19107	—
Unniversity of Pittsburgh Medical Center	Pittsburgh	Pennsylvania	15213	—
Vitreoretinal Consultants	Houston	Texas	77030	—
John A. Moran Eye Center, University of Utah	Salt Lake City	Utah	84132	—
University of Washington	Seattle	Washington	98104	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02374060, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Dec 3, 2018 · Synced Jul 22, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02374060 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →